4//SEC Filing
Leonard Reid 4
Accession 0000899243-21-048768
CIK 0001785530other
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 4:17 PM ET
Size
7.7 KB
Accession
0000899243-21-048768
Insider Transaction Report
Form 4
Leonard Reid
Chief Operating Officer
Transactions
- Sale
Common Stock
2021-12-15$13.97/sh−135$1,886→ 122,157 total(indirect: By Trust) - Sale
Common Stock
2021-12-15$13.39/sh−2,865$38,355→ 122,292 total(indirect: By Trust)
Footnotes (3)
- [F1]The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2021.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.84 to $13.78, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) of this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.93 to $13.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) of this Form 4.
Documents
Issuer
Werewolf Therapeutics, Inc.
CIK 0001785530
Entity typeother
Related Parties
1- filerCIK 0001857795
Filing Metadata
- Form type
- 4
- Filed
- Dec 16, 7:00 PM ET
- Accepted
- Dec 17, 4:17 PM ET
- Size
- 7.7 KB